Apocrine carcinoma

Apocrine carcinoma is a cancer of a sweat gland.  Apocrine carcionoma most often develops under the arm (the axilla), but it can develop on the scalp or other parts of the body.^[1][2]  The cause of apocrine carcinoma is unknown.  Apocrine carcinoma usually appears as a single, small, painless bump (nodule) that can vary in color and slowly increases in size.^[1][2]  The average age at the time of diagnosis is 62 years of age, and twice as many men are affected than women.^[2]  Most apocrine carcinomas can be treated and are not fatal.^[2][3]  Treatment of apocrine carcinoma is surgery to remove as much of the cancer as possible.^[1][2][3]  Additional treatments such as radiation therapy and chemotherapy have been used to treat this condition, but the usefulness of these treatments is unproven.^[3]

NCATS Co-Sponsored Conferences

• Advancing Symptom Clusters Research on Rare Cancers Wednesday, June 17, 2015
  Location: NIH Neuroscience Building, Bethesda, MD

  Description:

  It is intended that the in-depth, interdisciplinary dialogue of this expert working group will formulate an emerging consensus on a working definition of symptom clusters and, specific gaps and opportunities that provide a foundation for a transformative strategic blueprint to guide future symptom cluster research in rare cancers. In addition, it is anticipated that workshop proceedings will inform a funding opportunity announcement.

  Contact: Sue Marden, Ph.D.,(301) 496-9623,mardens@mail.nih.gov

  Co-funding Institute(s): National Institute of Nursing Research, Office of Rare Diseases Research

• Rare Tumors Initiative Symposium Strategies to Develop Therapies for Rare Tumors: Small Numbers, but Big Opportunities Wednesday, June 17, 2015
  Location: NIH Natcher Conference Center, Bethesda, MD

  Description: The goals of this symposium are to increase communication and build networks between researchers working in rare tumors across NIH, and to get input from patient groups, industry, and the FDA on how to overcome the biggest hurdles in the development of therapies for rare tumors. The Rare Tumors Initiative at NCI, CCR will use this information to prioritize goals for the future and will prepare a white paper summary to help guide researchers worldwide.

  Contact: Dr. Karlyne Reilly,(301) 846-7518, reillyk@mail.nih.gov

  Co-funding Institute(s): National Cancer Institute, Office of Rare Diseases Research

Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know. Submit a new question

• Do you have any information or case studies about a diagnosis of invasive apocrine carcinoma of axillary skin? I can't find much information about this rare disease. See answer